Navigation Links
Regulatory Leader in OASIS Documentation Introduces OASIS-C Products

DES MOINES, Iowa, Oct. 12 /PRNewswire/ -- Briggs, a leading provider of solutions to improve clinical outcomes and reduce operating costs in the home care market, today announced new OASIS-C products to meet extensive regulatory changes mandated by the Centers for Medicare & Medicaid Services (CMS).

The new OASIS-C products include Briggs' proprietary documentation for all OASIS assessment forms as well as a new online training course to support the regulatory changes.

The OASIS-C assessment enables home health care providers to capture more data while reducing the chance for errors and omissions in patient documentation. In addition to affecting the patients' program of care, errors and omissions can impact an agency's regulatory compliance, delay or minimize reimbursements and increase operating costs.

"Briggs' OASIS-C assessments include proprietary information to address three key areas: addressing problems before they become serious, treating existing conditions as efficiently as possible and intervention prior to re-hospitalization," says Sharon Hamilton, RN, BAB, CNLCP, CFDS, Briggs' Clinical Consultant-Home Care. "Unlike other assessments, Briggs provides the safeguards agencies need to stay compliant and maximize reimbursements."

Briggs backs up its new OASIS-C documentation with an online training course, accessible to home care clinicians through their computer. The 7-hour, 11 section course covers all the CMS changes, uses interactive modules to fully engage participants and offers pre- and post-testing features to help gauge improving proficiency.

In developing the OASIS-C products, Briggs has built on its core competencies as the regulatory leader in OASIS documentation. According to an independent study conducted by OCS, Inc., home care agencies using Briggs' OASIS forms report better outcomes for all CMS measurements, lower occurrence rates, reduced resource utilization and reduced costs per visit.

For more information regarding Briggs OASIS-C products, visit

About Briggs

Briggs is a leading supplier to more than 50,000 healthcare customers in the senior care, home care, acute care, physician and retail markets. Briggs produces and distributes more than 10,000 products including proprietary medical forms and documentation systems, durable and disposable medical supplies, charting materials and professional resources. Backed by clinical experience and regulatory knowledge, the company develops and markets products that are designed to improve clinical outcomes and reduce operating costs. The company has extensive international production capabilities and serves customers in five continents. For more information about Briggs, visit

Media Contact: Brooke Kelley, Public Relations Specialist, 1.800.247.2343,


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. EpiCept Reports Regulatory Progress on Ceplene(TM)
2. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
3. Anesiva Defines Regulatory Pathway for Adlea with FDA
4. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
5. EpiCept Provides Update on Clinical and Regulatory Progress with Ceplene(TM) and EpiCept(TM) NP-1 Cream
6. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
7. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
8. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
9. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
10. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
11. XTENT Announces European Regulatory Update
Post Your Comments:
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):